Extensive liver metastasis of gastric cancer effectively treated by hepatic arterial infusion of 5-fluorouracil/cisplatin

Gastric Cancer

Volumn 3, Issue 2, 2000, Pages 110-115

  Moriya, Akio ^a   Hyodo, Ichinosuke ^a   Nishina, Tomohiro ^a   Imaoka, Hiroya ^a   Imagawa, Atsushi ^a   Doi, Toshihiko ^a   Endo, Hisashi ^a   Tanimizu, Masahito ^a   Tajiri, Hisao ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

5 Fluorouracil; Cisplatin; Gastric cancer; Hepatic arterial infusion; Pharmacokinetics

Indexed keywords

BILIRUBIN; CISPLATIN; FLUOROURACIL; IRINOTECAN; METHOTREXATE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; DRUG EFFICACY; FIRST PASS EFFECT; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMPLANTABLE PORT SYSTEM; JAUNDICE; LIVER INJURY; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; TUMOR REGRESSION;

EID: 0034481405     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011695     Document Type: Article

References (17)

1. An early phase II study of a 3-hour infusion of pacliraxel for advanced gastric cancer
2. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M regafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients
3. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
4. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer
5. Combination of hepatic arterial infusion and systemic chemotherapy for gastric cancer with synchronous hepatic metastases
6. Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases
7. Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system
8. Arterial infusion chemotherapy for peritoneal and liver metastasis in gastric cancer
9. A case of Borrmann type 4 gastric cancer successfully treated with MTX and 5-FU therapy through the hepatic artery
10. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
11. Chemotherapy of advanced gastrointestinal cancer
12. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion
13. Regional chemotherapy devices: Effect of experience and anatomy on complications
14. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program Study
15. Phase II study of protracted infusion 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)
16. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
17. Dose versus pharmacokinetics for predicting tolerance to 5-day continuous infusion of 5-FU